HER-2/neu Assessment in Primary Chemotherapy Treated Breast Carcinoma: No Evidence of Gene Profile Changing

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.80, Iss.2, 2003-07, pp. : 207-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relevance of p185 HER-2/neu oncoprotein quantification in human primary breast carcinoma

By Bermont L.

Breast Cancer Research and Treatment, Vol. 63, Iss. 2, 2000-09 ,pp. : 163-169

Springer Publishing Company

Access to resources Recommend Favorite

Metaplastic breast carcinoma: clinical–pathologic characteristics and HER2/neu expression

By Barnes P.

Breast Cancer Research and Treatment, Vol. 91, Iss. 2, 2005-05 ,pp. : 173-178

Springer Publishing Company

Access to resources Recommend Favorite

HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer

By Konecny G.

Breast Cancer Research and Treatment, Vol. 69, Iss. 1, 2001-09 ,pp. : 53-63

Springer Publishing Company

Access to resources Recommend Favorite

Her-2/ neu Gene Amplification and Protein Expression in Primary Male Breast Cancer

By Rudlowski Christian

Breast Cancer Research and Treatment, Vol. 84, Iss. 3, 2004-04 ,pp. : 215-223

Springer Publishing Company

Access to resources Recommend Favorite

Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer

By Disis M.L. Knutson K.L. Schiffman K. Rinn K. McNeel D.G.

Breast Cancer Research and Treatment, Vol. 62, Iss. 3, 2000-08 ,pp. : 245-252

Springer Publishing Company

Access to resources Recommend Favorite